Finance

Lists
RMD:ASX
Resmed CDI
၃၁.၅၉ A$
-၀.၆၃%
(-၀.၂၀) 1D
အောက် ၅, GMT+၁၁ ၁၆:၁၀:၀၈  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RMD...
Open
၃၁.၆၇ A$
High
၃၁.၇၄ A$
Low
၃၁.၅၂ A$
Mkt. cap
ဋေ ၃.၁၀ ထ
Avg. vol.
၁.၁၂ သန်း
Volume
၃.၂၉ သိန်း
52-wk high
၄၃.၂၉ A$
52-wk low
၂၅.၅၀ A$
Shares outstanding
၁၄.၄၃ ကုဋေ
No. of employees
၁ သောင်း
Open
၃၁.၆၇ A$
High
၃၁.၇၄ A$
Low
၃၁.၅၂ A$
Mkt. cap
ဋေ ၃.၁၀ ထ
Avg. vol.
၁.၁၂ သန်း
Volume
၃.၂၉ သိန်း
52-wk high
၄၃.၂၉ A$
52-wk low
၂၅.၅၀ A$
Shares outstanding
၁၄.၄၃ ကုဋေ
No. of employees
၁ သောင်း
News stories
From web sources and news partners
TradingView
TradingView
·
ပြီးခဲ့သည့် ၁၁ နာရီ
ResMed (RMD): Buy, Sell, or Hold Post Q2 Earnings?
Kalkine
Kalkine
·
ပြီးခဲ့သည့် ၁၅ နာရီ
ResMed Inc Reports CDI and Common Stock Movements for September 2026
AD HOC NEWS
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁၉ နာရီ
ResMed stock fell 1.02 percent on October 2 before earnings
Investing.com
Investing.com
·
ပြီးခဲ့သည့် ၃ ရက်
Stifel reiterates Hold on ResMed stock amid market share concerns
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers. Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed CDI
CEOMichael J. Farrell
Employees၁.၁၄ သောင်း
Foundedဇွန် ၁၉၈၉
Headquartersဆန်ဒီရေဂို, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websiteresmed.com
Last report
၂၀၂၆ ဩ ၆
Fiscal period
Q4 2026
EPS / Est. (USD)
၀.၃၀ US$ / ၂.၈၉ US$
-၈၉.၈၀%miss
Revenue / Est. (USD)
၁၄၆.၃၆ ဋေ / ၁၄၆.၀၅ ဋေ
+၀.၂၁%beat
Fiscal Q4 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၁၃၃.၅၆ ဋေ
၁၄၂.၂၈ ဋေ
၁၄၃.၁၄ ဋေ
၁၄၆.၃၆ ဋေ
Cost of goods sold
၅၀.၆၉ ကုဋေ
၅၃.၆၃ ကုဋေ
၅၃.၂၆ ကုဋေ
၅၉.၄၁ ကုဋေ
Cost of revenue
၅၀.၆၉ ကုဋေ
၅၃.၆၃ ကုဋေ
၅၃.၂၆ ကုဋေ
၅၉.၄၁ ကုဋေ
Research and development expenses
၈.၇၃ ကုဋေ
၉.၁၀ ကုဋေ
၉.၄၃ ကုဋေ
၁၀.၅၇ ကုဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂၅.၉၂ ကုဋေ
၂၇.၅၇ ကုဋေ
၂၇.၉၈ ကုဋေ
၂၉.၃၄ ကုဋေ
Operating expense
၃၆.၆၃ ကုဋေ
၃၈.၆၂ ကုဋေ
၃၉.၃၂ ကုဋေ
၄၁.၇၉ ကုဋေ
Total operating expenses
၈၇.၃၂ ကုဋေ
၉၂.၂၅ ကုဋေ
၉၂.၅၇ ကုဋေ
၁၀၁.၂၀ ဋေ
Operating income
၄၆.၂၃ ကုဋေ
၅၀.၀၃ ကုဋေ
၅၀.၅၇ ကုဋေ
၄၅.၁၆ ကုဋေ
Other non operating income
-၃.၈၄ သန်း
၄.၂၀ သောင်း
၁.၈၁ သိန်း
၄.၄၀ သန်း
EBT including unusual items
၄၄.၆၈ ကုဋေ
၄၉.၆၁ ကုဋေ
၅၀.၂၃ ကုဋေ
၄၇.၄၂ ကုဋေ
EBT excluding unusual items
၄၆.၈၈ ကုဋေ
၅၀.၄၅ ကုဋေ
၅၁.၈၃ ကုဋေ
၄၇.၆၁ ကုဋေ
Income tax expense
၉.၈၃ ကုဋေ
၁၀.၃၆ ကုဋေ
၁၀.၃၆ ကုဋေ
၉.၀၇ ကုဋေ
Effective tax rate
၂၁.၉၉%
၂၀.၈၇%
၂၀.၆၂%
၁၉.၁၄%
Other operating expenses
-
-
-
-
Net income
၃၄.၈၅ ကုဋေ
၃၉.၂၆ ကုဋေ
၃၉.၈၇ ကုဋေ
၃၈.၃၄ ကုဋေ
Net profit margin
၂၆.၁၀%
၂၇.၅၉%
၂၇.၈၆%
၂၆.၂၀%
Earnings per share
၂.၅၅
၂.၈၁
၀.၂၉
၀.၃၀
Interest and investment income
၄.၆၉ သန်း
၄.၄၆ သန်း
၃.၈၀ သန်း
၃.၁၈ ကုဋေ
Interest expense
-
-
-
-
Net interest expenses
၄.၆၉ သန်း
၄.၄၆ သန်း
၃.၈၀ သန်း
၃.၁၈ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၅၀.၃၆ ကုဋေ
၅၄.၃၈ ကုဋေ
၅၅.၈၂ ကုဋေ
၄၉.၀၁ ကုဋေ
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ